HCV evades host antiviral innate immune responses to mediate a persistent infection in the liver. This review focuses on anti-HCV innate immune sensing, signaling and effectors and the processes ...
The survey also found that 75.2% had been exposed to the hepatitis C virus (anti-HCV prevalence), and 43.2% were co-infected ...
Targeting the entry process as an anti-hepatitis C virus strategy. HCV entry is a complex process involving multiple hepatocyte entry factors such as CD81, SR-BI, Claudin-1 and Occludin.
In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback